Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Therapeutic applications of iminosugars: current perspectives and future opportunities.

Horne G, Wilson FX.

Prog Med Chem. 2011;50:135-76. doi: 10.1016/B978-0-12-381290-2.00004-5. No abstract available.

PMID:
21315930
2.

Chemical modulators working at pharmacological interface of target proteins.

Jeon YH, Lee JY, Kim S.

Bioorg Med Chem. 2012 Mar 15;20(6):1893-901. doi: 10.1016/j.bmc.2011.12.016. Epub 2011 Dec 14. Review.

PMID:
22227462
3.

Iminosugars as therapeutic agents: recent advances and promising trends.

Nash RJ, Kato A, Yu CY, Fleet GW.

Future Med Chem. 2011 Sep;3(12):1513-21. doi: 10.4155/fmc.11.117. Review.

PMID:
21882944
4.

[Iminosugars: current and future therapeutic applications].

Martin O.

Ann Pharm Fr. 2007 Jan;65(1):5-13. Review. French.

PMID:
17299348
5.

Natural and synthetic iminosugars as carbohydrate processing enzyme inhibitors for cancer therapy.

Wrodnigg TM, Steiner AJ, Ueberbacher BJ.

Anticancer Agents Med Chem. 2008 Jan;8(1):77-85. Review.

PMID:
18220507
6.

Iminosugar antivirals: the therapeutic sweet spot.

Alonzi DS, Scott KA, Dwek RA, Zitzmann N.

Biochem Soc Trans. 2017 Apr 15;45(2):571-582. doi: 10.1042/BST20160182. Review.

7.

Discovery of iminosugar derivatives with strong IFN-gamma inducing activity.

Zhang L, Sun F, Wang Q, Zhou J, Zhang LH, Zhang XL, Ye XS.

ChemMedChem. 2009 May;4(5):756-60. doi: 10.1002/cmdc.200900027.

PMID:
19322802
8.

Structure-based organic synthesis of drug prototypes: a personal odyssey.

Hanessian S.

ChemMedChem. 2006 Dec;1(12):1301-30. Review. No abstract available.

PMID:
17091524
10.

Chemotherapy of bacterial and virus infections.

James DG.

Trans Med Soc Lond. 1979-1980;96:1-22. No abstract available.

PMID:
263097
11.

Iminosugars past, present and future: medicines for tomorrow.

Horne G, Wilson FX, Tinsley J, Williams DH, Storer R.

Drug Discov Today. 2011 Feb;16(3-4):107-18. doi: 10.1016/j.drudis.2010.08.017. Epub 2010 Sep 21. Review.

PMID:
20817006
12.

1,3,4-oxadiazole: a privileged structure in antiviral agents.

Li Z, Zhan P, Liu X.

Mini Rev Med Chem. 2011 Nov;11(13):1130-42. Review.

PMID:
22353222
13.

Spirocyclic nucleosides in medicinal chemistry: an overview.

Soengas RG, Silva S.

Mini Rev Med Chem. 2012 Dec;12(14):1485-96. Review.

PMID:
22827180
14.

Development and application of Hsp90 inhibitors.

Solit DB, Chiosis G.

Drug Discov Today. 2008 Jan;13(1-2):38-43. doi: 10.1016/j.drudis.2007.10.007. Epub 2007 Nov 26. Review.

PMID:
18190862
15.

C-Alkyl 5-membered ring imino sugars as new potent cytotoxic glucosylceramide synthase inhibitors.

Faugeroux V, Génisson Y, Andrieu-Abadie N, Colié S, Levade T, Baltas M.

Org Biomol Chem. 2006 Dec 21;4(24):4437-9. Epub 2006 Nov 2.

PMID:
17268635
16.

[Infectiology during change: prospects and controversies].

Kelm-Kahl I.

Dtsch Med Wochenschr. 1999 May 7;124(18):A7. German. No abstract available.

PMID:
10356576
17.

Alternative synthesis and antibacterial evaluation of 1,5-dideoxy-1,5-imino-L-rhamnitol.

Dharuman S, Wang Y, Crich D.

Carbohydr Res. 2016 Jan;419:29-32. doi: 10.1016/j.carres.2015.10.015. Epub 2015 Nov 4.

18.

Infectious complications in the cancer patient.

Bodey GP.

Curr Probl Cancer. 1977 Jun;1(12):1-63. Review. No abstract available.

PMID:
406117
19.

Fullerene sugar balls: a new class of biologically active fullerene derivatives.

Nierengarten I, Nierengarten JF.

Chem Asian J. 2014 Jun;9(6):1436-44. doi: 10.1002/asia.201400133. Epub 2014 Mar 26. Review.

PMID:
24678063
20.

Supplemental Content

Support Center